Table 1. Baseline characteristics of enrolled children at the time of administration of the first dose of IPTc.

Characteristics	IPTc	Placebo
	Percent (n/N)	Percent (n/N)
Age (mo)
3–11	18.2 (274/1,509)	18.5 (278/1,508)
12–23	22.5 (339/1,509)	20.5 (309/1,508)
24–35	20.5 (310/1,509)	22.0 (332/1,508)
36–47	20.0 (302/1,509)	19.4 (293/1,508)
48–59	18.8 (284/1,509)	19.6 (296/1,508)
Gender
Male	47.7 (720/1,509)	50.1 (755/1,508)
Female	52.3 (789/1,509)	49.9 (753/1,508)
Weight (kg)
5–9	34.8 (525/1,509)	34.7 (523/1,508)
10–8	63.1 (952/1,509)	63.2 (953/1,508)
≥19	2.1 (32/1,509)	2.1 (32/1,508)
Nutritional factors
Underweight	16.1 (238/1,480)	15.1 (223/1,477)
Wasting	11.0 (163/1,480)	12.5 (185/1,477)
Stunting	22.7 (336/1,480)	23.8 (352/1,477)
Fever	7.2 (105/1,460)	7.6 (111/1,464)